Inhibitory effects of silver nanoparticles against adenovirus type 3 in vitro

Journal of Virological Methods

Volumn 193, Issue 2, 2013, Pages 470-477

  Chen, Nana ^a   Zheng, Yang ^b   Yin, Jianjian ^a   Li, Xiujing ^a   Zheng, Conglong ^a  

^a DALIAN UNIVERSITY   (China)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

Adenovirus type 3; Inhibitory effects; Silver nanoparticles

Indexed keywords

SILVER NANOPARTICLE; VIRUS DNA;

ADENOVIRUS; ADENOVIRUS 3; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DNA ISOLATION; DRUG CYTOTOXICITY; HELA CELL; IN VITRO STUDY; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; TRANSMISSION ELECTRON MICROSCOPY; VIRUS INHIBITION; VIRUS PARTICLE;

ADENOVIRUS TYPE 3; INHIBITORY EFFECTS; SILVER NANOPARTICLES;

ADENOVIRUSES, HUMAN; ANTIVIRAL AGENTS; CELL SURVIVAL; CYTOPATHOGENIC EFFECT, VIRAL; DNA, VIRAL; EPITHELIAL CELLS; HELA CELLS; HUMANS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; REAL-TIME POLYMERASE CHAIN REACTION; SILVER; VIRION;

EID: 84882797597     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2013.07.020     Document Type: Article

References (38)

1. AshaRani P., Low Kah Mun G., Hande M.P., Valiyaveettil S. Cytotoxicity and genotoxicity of silver nanoparticles in human cells. ACS nano 2008, 3:279-290.
2. Bhumbra N., Wroblewski M.E. Adenovirus. Pediatrics in Review 2010, 31:173-174.
3. Bruno B., Gooley T., Hackman R.C., Davis C., Corey L., Boeckh M. Adenovirus infection in hematopoietic stem cell transplantation: effect of ganciclovir and impact on survival. Biology of Blood and Marrow Transplantation 2003, 9:341-352.
4. Chen X., Schluesener H.J. Nanosilver: a nanoproduct in medical application. Toxicology Letters 2008, 176:1-12.
5. Dingle J.H., Langmuir A.D. Epidemiology of acute, respiratory disease in military recruits. American Review of Respiratory Disease 1968, 97(Suppl):1-65.
6. Dorjnamjin D., Ariunaa M., Shim Y.K. Synthesis of silver nanoparticles using hydroxyl functionalized ionic liquids and their antimicrobial activity. International Journal of Molecular Sciences 2008, 9:807-820.
7. Echavarria M. Adenoviruses in immunocompromised hosts. Clinical Microbiology Reviews 2008, 21:704-715.
8. Elechiguerra J.L., Burt J.L., Morones J.R., Camacho-Bragado A., Gao X., Lara H.H., Yacaman M.J. Interaction of silver nanoparticles with HIV-1. Journal of Nanobiotechnology 2005, 3:1-10.
9. Feng Q.L., Wu J., Chen G.Q., Cui F.Z., Kim T.N., Kim J.O. A mechanistic study of the antibacterial effect of silver ions on Escherichia coli and Staphylococcus aureus. Journal of Biomedical Materials Research 2000, 52:662-668.
10. Freimoser F.M., Jakob C.A., Aebi M., Tuor U. The MTT [3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide] assay is a fast and reliable method for colorimetric determination of fungal cell densities. Applied and Environmental Microbiology 1999, 65:3727-3729.
11. Galdiero S., Falanga A., Vitiello M., Cantisani M., Marra V., Galdiero M. Silver nanoparticles as potential antiviral agents. Molecules 2011, 16:8894-8918.
12. Garnett C.T., Erdman D., Xu W., Gooding L.R. Prevalence and quantitation of species C adenovirus DNA in human mucosal lymphocytes. Journal of Virology 2002, 76:10608-10616.
13. Gustafsson D. Adenovirus Species B interactions with CD46, LNU 2012.
14. Hussain S.M., Javorina A.K., Schrand A.M., Duhart H.M., Ali S.F., Schlager J.J. The interaction of manganese nanoparticles with PC-12 cells induces dopamine depletion. Toxicological Sciences 2006, 92:456-463.
15. Kim H., Wyatt R., Fernie B., Brandt C., Arrobio J., Jeffries B., Parrott R. Respiratory syncytial virus detection by immunofluorescence in nasal secretions with monoclonal antibodies against selected surface and internal proteins. Journal of Clinical Microbiology 1983, 18:1399-1404.
16. Kinchington P.R., Romanowski E.G., Jerold Gordon Y. Prospects for adenovirus antivirals. Journal of Antimicrobial Chemotherapy 2005, 55:424-429.
17. Kojaoghlanian T., Flomenberg P., Horwitz M.S. The impact of adenovirus infection on the immunocompromised host. Reviews in Medical Virology 2003, 13:155-171.
18. La Rosa A.M., Champlin R.E., Mirza N., Gajewski J., Giralt S., Rolston K.V., Raad I., Jacobson K., Kontoyiannis D., Elting L., Whimbey E. Adenovirus infections in adult recipients of blood and marrow transplants. Clinical Infectious Diseases 2001, 32:871-876.
19. Lara H.H., Ayala-Núnez N.V., Ixtepan Turrent L.C., Rodríguez Padilla C. Bactericidal effect of silver nanoparticles against multidrug-resistant bacteria. World Journal of Microbiology and Biotechnology 2010, 26:615-621.
20. Lara H.H., Ayala-Nunez N.V., Ixtepan-Turrent L., Rodriguez-Padilla C. Mode of antiviral action of silver nanoparticles against HIV-1. Journal of Nanobiotechnology 2010, 8:1.
21. Lenaerts L., Naesens L. Antiviral therapy for adenovirus infections. Antiviral Research 2006, 71:172-180.
22. Lu L., Sun R.W., Chen R., Hui C.K., Ho C.M., Luk J.M., Lau G.K., Che C.M. Silver nanoparticles inhibit hepatitis B virus replication. Antiviral Therapy 2008, 13:253-262.
23. Morones J.R., Elechiguerra J.L., Camacho A., Holt K., Kouri J.B., Ramírez J.T., Yacaman M.J. The bactericidal effect of silver nanoparticles. Nanotechnology 2005, 16:2346.
24. Rai M., Yadav A., Gade A. Silver nanoparticles as a new generation of antimicrobials. Biotechnology Advances 2009, 27:76-83.
25. Rogers J.V., Parkinson C.V., Choi Y.W., Speshock J.L., Hussain S.M. A preliminary assessment of silver nanoparticle inhibition of monkeypox virus plaque formation. Nanoscale Research Letters 2008, 3:129-133.
26. Russell W. Adenoviruses: update on structure and function. Journal of General Virology 2009, 90:1-20.
27. Sirena D., Lilienfeld B., Eisenhut M., Kälin S., Boucke K., Beerli R.R., Vogt L., Ruedl C., Bachmann M.F., Greber U.F. The human membrane cofactor CD46 is a receptor for species B adenovirus serotype 3. Journal of Virology 2004, 78:4454-4462.
28. Sirikanchana K., Shisler J.L., Mariñas B.J. Effect of exposure to UV-C irradiation and monochloramine on adenovirus serotype 2 early protein expression and DNA replication. Applied and Environmental Microbiology 2008, 74:3774-3782.
29. Sivaraman S.K., Elango I., Kumar S., Santhanam V. A green protocol for room temperature synthesis of silver nanoparticles in seconds. Current Science 2009, 97:1055-1059.
30. Sondi I., Goia D.V., Matijevic E. Preparation of highly concentrated stable dispersions of uniform silver nanoparticles. Journal of Colloid Interface Science 2003, 260:75-81.
31. Speshock J.L., Murdock R.C., Braydich-Stolle L.K., Schrand A.M., Hussain S.M. Interaction of silver nanoparticles with Tacaribe virus. Journal of Nanobiotechnology 2010, 8:19.
32. Sun L., Singh A.K., Vig K., Pillai S.R., Singh S.R. Silver nanoparticles inhibit replication of respiratory syncytial virus. Journal of Biomedical Nanotechnology 2008, 4:149-158.
33. Suparno C., Milligan D.W., Moss P.A., Mautner V. Adenovirus infections in stem cell transplant recipients: recent developments in understanding of pathogenesis, diagnosis and management. Leukemia and Lymphoma 2004, 45:873-885.
34. Walls T., Shankar A.G., Shingadia D. Adenovirus: an increasingly important pathogen in paediatric bone marrow transplant patients. Lancet Infectious Diseases 2003, 3:79-86.
35. Wu E., Pache L., Von Seggern D.J., Mullen T.M., Mikyas Y., Stewart P.L., Nemerow G.R. Flexibility of the adenovirus fiber is required for efficient receptor interaction. Journal of Virology 2003, 77:7225-7235.
36. Xiang D., Chen Q., Pang L., Zheng C. Inhibitory effects of silver nanoparticles on H1N1 influenza A virus in vitro. Journal of Virological Methods 2011, 137-142.
37. Xu W.H., Erdman D.D. Type-specific identification of human adenovirus 3, 7, and 21 by a multiplex PCR assay. Journal of Medical Virology 2001, 64:537-542.
38. Yamanaka M., Hara K., Kudo J. Bactericidal actions of a silver ion solution on Escherichia coli, studied by energy-filtering transmission electron microscopy and proteomic analysis. Applied and Environmental Microbiology 2005, 71:89-93.